MRC Laboratory of Molecular Biology
One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.
Vivian, student artist who created a painting based on lysenin during Protein Data Bank in Europe’s art-science collaborative project, met with LMB’s Christos Savva, the scientist who discovered the structure of lysenin, at the opening of the Cambridge exhibition of artworks by The Leys students. More…
Alison Woollard, LMB 1996-2000, Postdoctoral Fellow, Cell Biology
Professor Alison Woollard, from the Department of Biochemistry at the University of Oxford, is this week’s guest on BBC Radio 4’s ‘The Life Scientific’. Alison explains her enthusiasm for the tiny nematode worm, C. elegans, and talks fondly of her time at the LMB. More…
Rebecca Taylor will be giving a talk at the UTC Cambridge as part of the Cambridge Science Festival. In her talk entitled, ‘Finding the fountain of youth: why we age and what we can do about it’, Rebecca will explain how her lab are using worms to understand how the nervous system coordinates the ageing process, and how it controls the health of cells as we get older. More…
Thursday 23rd March: 6:00pm – 7:00pm, UTC Cambridge, Robinson Way, CB2 0SZ
Brad Amos will be giving a talk at the UTC Cambridge as part of the Cambridge Science Festival. In his talk entitled, ‘Life through a lens’, Brad will show spectacular new 3D images of mouse embryos, possible due to his development of the Mesolens that achieves unparalleled resolution throughout a volume hundreds of times greater than a conventional microscope. More…
20 March: 6:00pm – 7:00pm, UTC Cambridge, Robinson Way, CB2 0SZ
The 16th annual Wiley Prize in Biomedical Sciences will be awarded to Joachim Frank, Richard Henderson, and Marin van Heel for pioneering developments in electron microscopy that are transforming structural studies of biological molecules and their complexes. More…
Leo James and Michel Goedert, group leaders at the LMB, recently published work in PNAS providing an explanation for how therapeutic antibodies eliminate pathogenic forms of tau protein. Here, Alzforum explore the background, results and implications of this study. More…